Anavex Life Sciences Corp.AVXLNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank50
Studio
Year-over-Year Change

Return on equity

Latest
-48.89%
↑ 37% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-77.73%
Historical baseline
PeriodValueYoY Change
2025-48.89%-36.7%
2024-35.76%-6.8%
2023-33.49%+0.5%
2022-33.67%-34.0%
2021-25.14%+73.9%
2020-96.49%+25.5%
2019-129.60%-52.2%
2018-85.17%-53.5%
2017-55.50%+76.2%
2016-233.61%-